Oramed Pharmaceuticals (ORMP) Stock Price, Quote, News & History | Benzinga

SPY777.29−0.16%QQQ743.86−0.99%BTC/USD83,548.22+2.22%DIA518.08+0.38%GLD382.24−0.61%TLT77.97−0.01%

Oramed Pharmaceuticals Inc (ORMP) Stock Price, Quote, News & History

ORMPNASDAQ

Trade with Public

Trade with Public

$4.27

-0.06-1.39%

Last update: Oct 12, 3:59 PM

OverviewNews Earnings Forecast Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$4.34

Close

$4.27

Volume / Avg.

64.70K / 192.52K

Day Range

$4.27 - $4.28

52 Wk Range

2.09 - 5.47

Market Cap

$180.12M

P/E Ratio

1.05

Dividend Yield

5.77%

Exchange

NASDAQ

RSI

36

Short Interest

4.07%

Days to Cover

7.33

Recent Oramed Pharmaceuticals Inc News

Top 4 Health Care Stocks That May Crash This Quarter

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Avi Kapoor

Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.

Lisa Levin

Dow Tumbles 250 Points; CarMax Posts Upbeat Results

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. Following the market opening Friday, the Dow traded down 0.74% to 33,695.28 while the NASDAQ fell 0.98% to 13,497.22. The S&P 500, also fell, dropping, 0.78% to 4,347.58.

Lisa Levin

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Lisa Levin

Why Oramed Pharmaceuticals Shares Are Trading Higher Today

Oramed Pharmaceuticals Inc (NASDAQ: ORMP) shares are trading higher after its partner completed Phase 3 trials of oral insulin in type 2 diabetes in China

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.21M

Investing Cash Flow (TTM)

21.50M

Financing Cash Flow (TTM)

-16.68M

Free Cash Flow (TTM)

-7.14M

Capital Expenditure (TTM)

-1.93M

Net Change in Cash (TTM)

-387.00K

Valuation Metrics

Enterprise Value

$130.45M

PE Ratio (TTM)

1.05

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.57

Earnings Yield % (TTM)

95.27%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

1.72

Price / EBITDA (TTM)

2.40

Price / Free Cash Flow (TTM)

-

Book Value / Share

$7.63

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$15.25M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-